drugset / Trial / NCT02619786

Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin

NCT02619786

Phase 3 Unknown 62 enrolled Mahidol University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether inhaled colistin is effective in the treatment of ventilator associated tracheobronchitis due to gram negative organism susceptible to colistin.

Timeline

Start
2015-12
Primary completion
2017-05
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Colistin Other / unclassified 75 mg Inhaled

Indications